-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
GSK Plc (NYSE:GSK) Given Average Recommendation of "Hold" by Brokerages
GSK Plc (NYSE:GSK) Given Average Recommendation of "Hold" by Brokerages
Shares of GSK plc (NYSE:GSK – Get Rating) have earned an average recommendation of "Hold" from the fifteen research firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $1,508.75.
A number of brokerages have commented on GSK. StockNews.com raised shares of GSK from a "buy" rating to a "strong-buy" rating in a report on Thursday. Barclays reduced their target price on shares of GSK from GBX 1,800 ($22.29) to GBX 1,450 ($17.95) in a report on Friday, October 14th. JPMorgan Chase & Co. cut shares of GSK from a "neutral" rating to an "underweight" rating in a report on Tuesday, January 3rd. UBS Group cut shares of GSK from a "neutral" rating to a "sell" rating in a research note on Friday, November 11th. Finally, TheStreet raised shares of GSK from a "c+" rating to a "b-" rating in a research note on Friday, December 30th.
Get GSK alerts:Hedge Funds Weigh In On GSK
Several institutional investors have recently bought and sold shares of GSK. Pflug Koory LLC purchased a new position in GSK during the third quarter valued at $26,000. Northwest Investment Counselors LLC grew its stake in GSK by 339.0% during the fourth quarter. Northwest Investment Counselors LLC now owns 777 shares of the pharmaceutical company's stock valued at $27,000 after acquiring an additional 600 shares in the last quarter. Castle Wealth Management LLC purchased a new position in GSK during the second quarter valued at $28,000. Householder Group Estate & Retirement Specialist LLC purchased a new position in GSK during the third quarter valued at $31,000. Finally, CX Institutional bought a new position in GSK during the second quarter valued at $32,000. 13.15% of the stock is owned by hedge funds and other institutional investors.
GSK Stock Down 0.1 %
Shares of GSK stock opened at $35.30 on Friday. The company has a market cap of $72.26 billion, a price-to-earnings ratio of 4.33, a price-to-earnings-growth ratio of 1.23 and a beta of 0.66. The company's 50 day moving average is $35.12 and its 200 day moving average is $34.38. GSK has a twelve month low of $28.47 and a twelve month high of $46.97. The company has a quick ratio of 0.74, a current ratio of 0.97 and a debt-to-equity ratio of 2.22.GSK (NYSE:GSK – Get Rating) last announced its earnings results on Wednesday, November 2nd. The pharmaceutical company reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.19. GSK had a net margin of 37.88% and a return on equity of 32.18%. The business had revenue of $9.22 billion during the quarter, compared to analysts' expectations of $7.75 billion. Research analysts anticipate that GSK will post 3.31 EPS for the current year.
GSK Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, January 12th. Investors of record on Friday, November 18th were paid a dividend of $0.3695 per share. The ex-dividend date of this dividend was Thursday, November 17th. This represents a $1.48 annualized dividend and a yield of 4.19%. GSK's payout ratio is 16.05%.
GSK Company Profile
(Get Rating)
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation.
Further Reading
- Get a free copy of the StockNews.com research report on GSK (GSK)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with MarketBeat.com's FREE daily email newsletter.
据Marketbeat.com报道,葛兰素史克公司(NYSE:GSK-GET Rating)的股票在涵盖该股的15家研究公司中平均被评为持有。三名投资分析师对该股的评级为卖出建议,四名分析师发布了持有建议,两名分析师给出了买入建议,一名分析师给出了强烈的买入建议。在过去一年更新该股覆盖范围的券商中,12个月目标价的平均水平为1,508.75美元。
多家券商对葛兰素史克发表了评论。在周四的一份报告中,StockNews.com将葛兰素史克的股票评级从“买入”上调至“强力买入”。在10月14日星期五的一份报告中,巴克莱将葛兰素史克股票的目标价从1800英镑(22.29美元)下调至1450英镑(17.95美元)。摩根大通公司在1月3日周二的一份报告中将葛兰素史克的股票评级从中性下调至减持。在11月11日星期五的一份研究报告中,瑞银集团将葛兰素史克的股票评级从中性下调至卖出。最后,华尔街在12月30日星期五的一份研究报告中将葛兰素史克的股票评级从“c+”上调至“b-”。
到达葛兰素史克警报:对冲基金对葛兰素史克持股
几家机构投资者最近买卖了葛兰素史克的股票。Pflug Koory LLC在第三季度购买了葛兰素史克的新头寸,价值2.6万美元。西北投资顾问有限责任公司在第四季度增持了339.0%的葛兰素史克股份。西北投资顾问有限责任公司在上个季度增持了600股后,现在持有这家制药公司777股股票,价值27,000美元。Castle Wealth Management LLC在第二季度购买了葛兰素史克的新头寸,价值2.8万美元。家庭所有者集团房地产和退休专业公司LLC在第三季度购买了GSK的一个新头寸,价值3.1万美元。最后,CX机构在第二季度买入了价值3.2万美元的葛兰素史克新头寸。13.15%的股票由对冲基金和其他机构投资者持有。
葛兰素史克股价下跌0.1%
葛兰素史克股票上周五开盘报35.30美元。该公司市值为722.6亿美元,市盈率为4.33倍,市盈率为1.23倍,贝塔系数为0.66。该公司的50日移动均线切入位在35.12美元,200日移动均线切入位在34.38美元。葛兰素史克的12个月低点为28.47美元,12个月高位为46.97美元。该公司的速动比率为0.74,流动比率为0.97,债务权益比率为2.22。葛兰素史克(NYSE:GSK-GET Rating)最近一次公布盈利业绩是在11月2日星期三。这家制药公司公布本季度每股收益为1.09美元,高于分析师普遍预期的0.90美元和0.19美元。葛兰素史克的净利润率为37.88%,股本回报率为32.18%。该业务当季营收为92.2亿美元,高于分析师预期的77.5亿美元。研究分析师预计,葛兰素史克本年度每股收益将达到3.31欧元。
葛兰素史克削减股息
该公司最近还宣布了季度股息,股息于1月12日星期四支付。在11月18日(星期五)登记在册的投资者获得了每股0.3695美元的股息。本次股息除息日期为11月17日星期四。这意味着年化股息为1.48美元,收益率为4.19%。葛兰素史克的派息率为16.05%。
GSK公司简介
(获取评级)
葛兰素史克是一家医疗保健公司,从事药品、疫苗和消费者保健产品的研究、开发和制造。它通过以下部门开展业务:制药、药品研发、疫苗和消费者保健。药品部门专注于开发呼吸系统和传染病、肿瘤学和免疫炎症方面的药物。
进一步阅读
- 免费获取StockNews.com关于葛兰素史克(GSK)的研究报告
- 市场回顾周-1/23-1/27
- 为什么Lucid在一天内飙升了近100%
- 利用这些铁路股票实现增长和收入
- ASML预计今年芯片需求回升,提振销售观点
- KLA公司:在动荡不安的半市场中站稳脚跟
接受GSK日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对GSK和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧